...Janssen has rights to Yondelis outside of Europe and Japan from PharmaMar, a subsidiary of Zeltia S.A....

...alkaloid that binds the minor groove of DNA in Japan from PharmaMar, a subsidiary of Zeltia S.A....

...a baseline IOP of >=25 mmHg. Bamosiran was well tolerated. Sylentis is a subsidiary of Zeltia S.A....

...unit has rights to Yondelis outside of Europe and Japan from PharmaMar, a subsidiary of Zeltia S.A....

...Ewing’s family of tumors and carcinoma of unknown primary site. PharmaMar is a subsidiary of Zeltia S.A....

...Johnson has rights to Yondelis outside of Europe and Japan from PharmaMar, a subsidiary of Zeltia S.A....

...unit has rights to Yondelis outside of Europe and Japan from PharmaMar, a subsidiary of Zeltia S.A....

...vs. pegylated liposomal doxorubicin or topotecan in about 420 patients. PharmaMar is a subsidiary of Zeltia S.A....

...at the American Society of Clinical Oncology meeting in Chicago. PharmaMar is a subsidiary of Zeltia S.A....

...Janssen has rights to Yondelis outside of Europe and Japan from PharmaMar, a subsidiary of Zeltia S.A....